Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate possible problems or questions in safety and effectiveness of salmeterol and fluticasone in patients with chronic obstructive pulmonary disease (bronchitis chronic / emphysema). In this special drug use investigation, onset of pneumonia shall be handled as the priority investigation item.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Drug Combination; Salmeterol Xinafoate

Criteria

Inclusion Criteria:

• Must use salmeterol and fluticasone for the first time

Exclusion Criteria:

• Patients with hypersensitivity to salmeterol and fluticasone

• Patients with infection which salmeterol and fluticasone is not effective

• Patients with deep mycosis